188 related articles for article (PubMed ID: 28847527)
1. The safety and pharmacokinetics of high dose intravenous ascorbic acid synergy with modulated electrohyperthermia in Chinese patients with stage III-IV non-small cell lung cancer.
Ou J; Zhu X; Lu Y; Zhao C; Zhang H; Wang X; Gui X; Wang J; Zhang X; Zhang T; Pang CLK
Eur J Pharm Sci; 2017 Nov; 109():412-418. PubMed ID: 28847527
[TBL] [Abstract][Full Text] [Related]
2. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia.
Tarng DC; Wei YH; Huang TP; Kuo BI; Yang WC
Kidney Int; 1999 Jun; 55(6):2477-86. PubMed ID: 10354297
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer.
Ou J; Zhu X; Chen P; Du Y; Lu Y; Peng X; Bao S; Wang J; Zhang X; Zhang T; Pang CLK
J Adv Res; 2020 Jul; 24():175-182. PubMed ID: 32368355
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravenous ascorbic acid on erythropoiesis and quality of life in unselected hemodialysis patients.
Taji Y; Morimoto T; Okada K; Fukuhara S; Fukui T; Kuwahara T
J Nephrol; 2004; 17(4):537-43. PubMed ID: 15372416
[TBL] [Abstract][Full Text] [Related]
5. Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.
Bazzan AJ; Zabrecky G; Wintering N; Newberg AB; Monti DA
Integr Cancer Ther; 2018 Sep; 17(3):912-920. PubMed ID: 29771164
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
7. Effect of Modulated Electrohyperthermia on the Pharmacokinetics of Oral Transmucosal Fentanyl Citrate in Healthy Volunteers.
Lee SY; Kim MG
Clin Ther; 2016 Dec; 38(12):2548-2554. PubMed ID: 27866658
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.
DeVore RF; Johnson DH; Crawford J; Garst J; Dimery IW; Eckardt J; Eckhardt SG; Elfring GL; Schaaf LJ; Hanover CK; Miller LL
J Clin Oncol; 1999 Sep; 17(9):2710-20. PubMed ID: 10561345
[TBL] [Abstract][Full Text] [Related]
9. DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial.
Payne M; Ellis P; Dunlop D; Ranson M; Danson S; Schacter L; Talbot D
J Thorac Oncol; 2006 Nov; 1(9):984-90. PubMed ID: 17409983
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the effects of mEHT on the treatment-related toxicity and quality of life of HIV-positive cervical cancer patients.
Minnaar CA; Kotzen JA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
Int J Hyperthermia; 2020; 37(1):263-272. PubMed ID: 32180481
[No Abstract] [Full Text] [Related]
11. Oxidant stress and B vitamins status in patients with non-small cell lung cancer.
Tsao SM; Yin MC; Liu WH
Nutr Cancer; 2007; 59(1):8-13. PubMed ID: 17927496
[TBL] [Abstract][Full Text] [Related]
12. Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: a pharmacokinetic evaluation.
Nielsen TK; Højgaard M; Andersen JT; Poulsen HE; Lykkesfeldt J; Mikines KJ
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):343-8. PubMed ID: 25220574
[TBL] [Abstract][Full Text] [Related]
13. Brief Report: Stability and Chemical Characteristics of Injectable Ascorbic Acid for Patients With Cancer.
Monti DA; Bazzan AJ; Zabrecky G; Newberg AB
Altern Ther Health Med; 2019 Mar; 25(2):42-45. PubMed ID: 28987078
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.
Yasuda H; Yamaya M; Nakayama K; Sasaki T; Ebihara S; Kanda A; Asada M; Inoue D; Suzuki T; Okazaki T; Takahashi H; Yoshida M; Kaneta T; Ishizawa K; Yamanda S; Tomita N; Yamasaki M; Kikuchi A; Kubo H; Sasaki H
J Clin Oncol; 2006 Feb; 24(4):688-94. PubMed ID: 16446342
[TBL] [Abstract][Full Text] [Related]
15. Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.
Stephenson CM; Levin RD; Spector T; Lis CG
Cancer Chemother Pharmacol; 2013 Jul; 72(1):139-46. PubMed ID: 23670640
[TBL] [Abstract][Full Text] [Related]
16. Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer: A Retrospective Observational Study on 106 Patients.
Fiorentini G; Sarti D; Casadei V; Milandri C; Dentico P; Mambrini A; Nani R; Fiorentini C; Guadagni S
Integr Cancer Ther; 2019; 18():1534735419878505. PubMed ID: 31561722
[No Abstract] [Full Text] [Related]
17. Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro- hyperthermia.
Kuo IM; Lee JJ; Wang YS; Chiang HC; Huang CC; Hsieh PJ; Han W; Ke CH; Liao ATC; Lin CS
BMC Cancer; 2020 Jun; 20(1):603. PubMed ID: 32600429
[TBL] [Abstract][Full Text] [Related]
18. A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Herbst RS; Hammond LA; Carbone DP; Tran HT; Holroyd KJ; Desai A; Williams JI; Bekele BN; Hait H; Allgood V; Solomon S; Schiller JH
Clin Cancer Res; 2003 Sep; 9(11):4108-15. PubMed ID: 14519633
[TBL] [Abstract][Full Text] [Related]
19. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.
Lau D; Leigh B; Gandara D; Edelman M; Morgan R; Israel V; Lara P; Wilder R; Ryu J; Doroshow J
J Clin Oncol; 2001 Jan; 19(2):442-7. PubMed ID: 11208837
[TBL] [Abstract][Full Text] [Related]
20. Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia.
Chi MS; Mehta MP; Yang KL; Lai HC; Lin YC; Ko HL; Wang YS; Liao KW; Chi KH
Front Oncol; 2020; 10():254. PubMed ID: 32211319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
